Transcode Therapeutics, Inc.
RNAZ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829635
No open-market purchases or sales by Transcode Therapeutics, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $208.1K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Transcode Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 17 | 16 | −1 |
| Shares | 2.44M | 2.35M | −81.7K (−3.4%) |
| Value | $7.28M | $5.98M | −$1.30M (−17.9%) |
New holders (4)
Institutions that held Transcode Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Redmond Asset Management, LLC | 88,010 | $224.0K | 0.06% |
| K.J. Harrison & Partners Inc | 16,000 | $41.0K | 0.01% |
| High Net Worth Advisory Group LLC | 2,500 | $6.00K | 0.00% |
| Royal Bank of Canada | 49 | $0 | 0.00% |
Sold out (5)
Institutions that held Transcode Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Citadel Advisors LLC | 90,774 | $271.0K |
| Two Sigma Investments, LP | 76,645 | $229.0K |
| Two Sigma Securities, LLC | 33,314 | $100.0K |
| National Asset Management, Inc. | 25,000 | $75.0K |
| Virtu Financial LLC | 18,064 | $54.0K |